Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences.
about
Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?Epidemiology and clinical course of Crohn's disease: results from observational studiesWhere are we on worms?Inflammatory bowel disease in australasian children and adolescentsEpidemiological studies of migration and environmental risk factors in the inflammatory bowel diseasesLinking vitamin d deficiency to inflammatory bowel diseasePulmonary-intestinal cross-talk in mucosal inflammatory diseaseInflammatory bowel disease in India - Past, present and futureMycobacterium paratuberculosis as a cause of Crohn's diseaseAssessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.Efficacy of early immunomodulator therapy on the outcomes of Crohn's disease.Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trialClinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia.Electroacupuncture improves trinitrobenzene sulfonic Acid-induced colitis, evaluated by transcriptomic studyFamilial aggregation of inflammatory bowel disease in patients with ulcerative colitisVitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment.Protective association of tumor necrosis factor superfamily 15 (TNFSF15) polymorphic haplotype with Ulcerative Colitis and Crohn's disease in an Indian population.Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.Inventory of a reservoir: friends & foesBone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice.Diterpenoid alkaloids of Aconitum laciniatum and mitigation of inflammation by 14-O-acetylneoline in a murine model of ulcerative colitis.Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease.Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea.Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul.Crohn's and colitis in children and adolescents.The Role of the Microbiome and the use Of Probiotics in Gastrointestinal Disorders in Adults in the Asia-Pacific Region.Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn's disease and discriminative value of FOXP3 mRNA expression.Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases.Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients.Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease.Plasma long noncoding RNA expression profile identified by microarray in patients with Crohn's disease.Helicobacter pylori and Crohn's disease: a retrospective single-center study from ChinaSeasonal variation in months of birth and symptom flares in Korean patients with inflammatory bowel disease.Development and Application of a Plant-Based Diet Scoring System for Japanese Patients with Inflammatory Bowel Disease.The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity.Making sense of the cause of Crohn's - a new look at an old disease.The incidence rate of inflammatory bowel disease in an urban area of iran: a developing country.Efficacy and safety of adalimumab in Crohn's disease: meta-analysis of placebo-controlled trials.Interaction between susceptibility and environment: examples from the digestive tract.Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence.
P2860
Q21198788-D6964E6F-69C0-4541-948A-270C64D98C9BQ22241217-3C2E6CA0-CEC0-468E-8F71-ECCE604A71DDQ22242718-54386C71-4CE0-4304-85BC-B5CB107080CFQ26823945-E8046B68-2C13-4E09-96C9-AFF7CACE0643Q26830881-EFFA1C07-97D3-4B1A-9845-1FDA2E4B027BQ27014858-BACD190F-34C0-4973-90C2-44F1740722DBQ27693862-CDE5EE5B-BA03-4791-AFD6-79614DABF3BCQ28079050-F1B02486-BD68-4394-9DD6-3305550EC3E1Q28081602-0405BB55-6EFB-44B4-AEA6-C42DD4994847Q31034250-51F6DCD1-DE1A-4FA7-8A7D-BCAC7381161AQ33595056-28BA5F34-8116-4250-B927-87C22DDF90F4Q33646487-DD58D184-F900-4282-AEDC-0D890912C0EAQ33796025-BFDEC28E-8EF3-45ED-BA8F-188D58302611Q33796809-4AFA2F7F-4B97-4374-ABA4-DBA221647E4FQ33819525-34258C77-21AB-478C-AA35-CF95C91B3F38Q33828491-97CFC9C1-E28E-4392-841F-15CEC47E6612Q34689761-5CFA8C31-7F43-4B1F-A60D-FD45DC7FDBAAQ35012080-69D11A9A-DB11-4D8E-9439-F0040262DCE8Q35742141-5E7A5019-6B35-40D5-90AB-DC6CD47E80D7Q35826470-8ACB808D-C9F9-4618-AC8D-A754E5C951DDQ35913346-2818B81B-9DEE-47AD-8875-4F85B0CFD05EQ35971472-AB25EA46-BB82-42FA-9DF6-1302CB743BDAQ36043775-8649E512-DAF3-452D-9C0E-6A36AAD969DBQ36081382-DF6C5ED7-4B89-4B00-ACBA-DB19B029595CQ36378775-2913B65F-3AA2-48C7-8B1D-453EE5C80822Q36394638-1D6776F0-0B24-47CA-A6E7-4CF27FD3B103Q36596782-EB361B0D-F77E-417E-878D-5732FDEE4AC8Q36702482-CADB2E1B-60F8-4447-8247-5185A82EB095Q36819607-4616789A-76A2-4DFA-AF14-F3C229ECE538Q36848949-1B667CAE-C66B-4E3A-9296-873EF41F5192Q36909245-C8261714-C239-402A-8280-B4703071C6BEQ37050515-6FFD8CE4-486E-457F-BCE1-D19BB626C183Q37359356-7F0EC5E7-3F0E-4BF0-8055-E9D90E5851EDQ37401965-50F25C8C-9191-4404-8E9B-1144AEE42366Q37530552-84287CCB-4B08-410A-93FF-1BE936281252Q37577712-EC8306D0-3082-4E19-B6BB-55E20B502A74Q37733980-A74F2271-6CF9-446D-80C2-A6E4FC04E638Q37880288-7CEAEC38-1D99-4A28-A007-DE1BF762DA38Q37898402-7023A61B-65F5-41B1-83A3-FF15FDBEC3F5Q37996392-5D47215C-AAEC-402E-84D2-4097C197FBAF
P2860
Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory bowel disease in ...... ries and regional differences.
@en
Inflammatory bowel disease in ...... ries and regional differences.
@nl
type
label
Inflammatory bowel disease in ...... ries and regional differences.
@en
Inflammatory bowel disease in ...... ries and regional differences.
@nl
prefLabel
Inflammatory bowel disease in ...... ries and regional differences.
@en
Inflammatory bowel disease in ...... ries and regional differences.
@nl
P2860
P1476
Inflammatory bowel disease in ...... ries and regional differences.
@en
P2093
Rakesh K Tandon
Vineet Ahuja
P2860
P304
P356
10.1111/J.1751-2980.2010.00429.X
P577
2010-06-01T00:00:00Z